{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:26:04Z","timestamp":1684470364307},"reference-count":40,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.molimm.2008.05.008","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T09:36:00Z","timestamp":1214386560000},"page":"3526-3535","source":"Crossref","is-referenced-by-count":3,"title":["Cartilage proteoglycan-specific T cells as vectors of immunomodulatory biologicals in chronic proteoglycan-induced arthritis"],"prefix":"10.1016","volume":"45","author":[{"given":"Teun","family":"Guichelaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corlinda B.","family":"ten Brink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"van Kooten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne E.","family":"Berlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floris P.","family":"Lafeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris. P.","family":"Broeren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem","family":"van Eden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"Broere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2008.05.008_bib1","doi-asserted-by":"crossref","first-page":"10764","DOI":"10.1073\/pnas.90.22.10764","article-title":"Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer","volume":"90","author":"Bandara","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2008.05.008_bib2","doi-asserted-by":"crossref","first-page":"6013","DOI":"10.4049\/jimmunol.168.12.6013","article-title":"T and B cell recovery in arthritis adoptively transferred to SCID mice: antigen-specific activation is required for restoration of autopathogenic CD4+ Th1 cells in a syngeneic system","volume":"168","author":"Bardos","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1084\/jem.20011629","article-title":"In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines","volume":"195","author":"Barrat","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2008.05.008_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jaut.2005.09.017","article-title":"Naive transgenic T cells expressing cartilage proteoglycan-specific TCR induce arthritis upon in vivo activation","volume":"25","author":"Berlo","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.molimm.2008.05.008_bib5","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1002\/art.22013","article-title":"Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice","volume":"54","author":"Berlo","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2008.05.008_bib6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nri1574","article-title":"Regulatory T-cell therapy: is it ready for the clinic?","volume":"5","author":"Bluestone","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-003-0127-1","article-title":"Immunopathogenesis of collagen arthritis","volume":"25","author":"Brand","year":"2003","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.molimm.2008.05.008_bib8","doi-asserted-by":"crossref","first-page":"6908","DOI":"10.4049\/jimmunol.165.12.6908","article-title":"Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile","volume":"165","author":"Broeren","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib9","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.4049\/jimmunol.155.5.2679","article-title":"A proteoglycan (aggrecan)-specific T cell hybridoma induces arthritis in BALB\/c mice","volume":"155","author":"Buzas","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib10","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.164.7.3581","article-title":"Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease","volume":"164","author":"Costa","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00062752-200101000-00009","article-title":"Th1 and Th2 cells","volume":"8","author":"Dong","year":"2001","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.molimm.2008.05.008_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0022-1759(86)90322-4","article-title":"A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor\/tumor necrosis factor from human monocytes","volume":"95","author":"Espevik","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2008.05.008_bib13","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.4049\/jimmunol.163.10.5383","article-title":"Proteoglycan (aggrecan)-induced arthritis in BALB\/c mice is a Th1-type disease regulated by Th2 cytokines","volume":"163","author":"Finnegan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib14","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.4049\/jimmunol.169.6.3345","article-title":"IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms","volume":"169","author":"Finnegan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1615\/CritRevImmunol.v23.i3.20","article-title":"Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics","volume":"23","author":"Glant","year":"2003","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.55.1.40","article-title":"Cellular immunity to cartilage aggrecan core protein in patients with rheumatoid arthritis and non-arthritic controls","volume":"55","author":"Goodstone","year":"1996","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.molimm.2008.05.008_bib17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2008.05.008_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/1529-0131(199806)41:6<1019::AID-ART8>3.0.CO;2-X","article-title":"Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate","volume":"41","author":"Guerassimov","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2008.05.008_bib19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/art.20180","article-title":"Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype","volume":"50","author":"Hanyecz","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2008.05.008_bib20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2249.2000.01174.x","article-title":"Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB\/c mice with proteoglycan (aggrecan)-induced arthritis","volume":"120","author":"Hollo","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/ar383","article-title":"Th1 and Th2 cytokines regulate proteoglycan-specific autoantibody isotypes and arthritis","volume":"4","author":"Kaplan","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.molimm.2008.05.008_bib22","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nm1195-1162","article-title":"Gene transfer through the blood-nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis","volume":"1","author":"Kramer","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.molimm.2008.05.008_bib23","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/sj.cr.7290034","article-title":"Isolation and characteristics of autoreactive T cells specific to aggrecan G1 domain from rheumatoid arthritis patients","volume":"10","author":"Li","year":"2000","journal-title":"Cell Res."},{"key":"10.1016\/j.molimm.2008.05.008_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4049\/jimmunol.173.1.151","article-title":"Inducing experimental arthritis and breaking self-tolerance to joint-specific antigens with trackable, ovalbumin-specific T cells","volume":"173","author":"Maffia","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib26","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/art.1780370919","article-title":"Migration and homing of lymphocytes to lymphoid and synovial tissues in proteoglycan-induced murine arthritis","volume":"37","author":"Mikecz","year":"1994","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2008.05.008_bib27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1067\/mai.2002.127512","article-title":"CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation","volume":"110","author":"Oh","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib28","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.174.6.3781","article-title":"Antigen-specific B cells are required as APCs and autoantibody-producing cells for induction of severe autoimmune arthritis","volume":"174","author":"O\u2019Neill","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib29","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1084\/jem.182.5.1357","article-title":"Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations","volume":"182","author":"Openshaw","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2008.05.008_bib30","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/sj.gt.3302040","article-title":"Gene therapy for arthritis","volume":"10","author":"Robbins","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.molimm.2008.05.008_bib31","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4049\/jimmunol.163.3.1205","article-title":"Peptide dose, affinity, and time of differentiation can contribute to the Th1\/Th2 cytokine balance","volume":"163","author":"Rogers","year":"1999","journal-title":"J. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.molimm.2008.05.008_bib32","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar1703","article-title":"The role of the T cell in autoimmune inflammation","volume":"7","author":"Skapenko","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.molimm.2008.05.008_bib33","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.21108","article-title":"Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist","volume":"52","author":"Smeets","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.molimm.2008.05.008_bib34","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301980","article-title":"Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritis","volume":"10","author":"Smith","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.molimm.2008.05.008_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1006\/clim.2002.5299","article-title":"Retroviral gene therapy of collagen-induced arthritis by local delivery of IL-4","volume":"105","author":"Tarner","year":"2002","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.molimm.2008.05.008_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1196\/annals.1254.067","article-title":"Treatment of autoimmune disease by adoptive cellular gene therapy","volume":"998","author":"Tarner","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2008.05.008_bib37","first-page":"1147","article-title":"Identification of self-epitopes recognized by T cells in rheumatoid arthritis demonstrates matrix metalloproteinases as a novel T cell target","volume":"30","author":"ter Steege","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.molimm.2008.05.008_bib38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/ar1214","article-title":"Gene therapy in animal models of rheumatoid arthritis: are we ready for the patients?","volume":"6","author":"van de Loo","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.molimm.2008.05.008_bib39","first-page":"33","article-title":"What are the risks of biologic therapy in rheumatoid arthritis? An update on safety","volume":"65","author":"Weisman","year":"2002","journal-title":"J. Rheumatol. Suppl."},{"key":"10.1016\/j.molimm.2008.05.008_bib40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/ni1105-1069","article-title":"T(H)-17: a giant step from T(H)1 and T(H)2","volume":"6","author":"Wynn","year":"2005","journal-title":"Nat. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589008001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589008001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:47:56Z","timestamp":1684453676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589008001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":40,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0161589008001995"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2008.05.008","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}